Silencing the androgen receptor: New skills for antiandrogen oligonucleotide skin and hair therapy

Journal of Dermatological Science

Volumn 54, Issue 2, 2009, Pages 123-125

  Dugour, Andrea ^a   Hagelin, Karin ^a   Smus, Cintia ^a   Balañá, María Eugenia ^a   Kerner, Néstor ^a  

^a Fundacion Pablo Cassara   (Argentina)

Author keywords

Antiandrogen oligonucleotides; Cutaneous therapy; Skin and hair

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANOLONE; ANTISENSE OLIGONUCLEOTIDE; FINASTERIDE; ISOTRETINOIN; OLIGONUCLEOTIDE; SMALL INTERFERING RNA; TESTOSTERONE;

ACNE; ACNE VULGARIS; GENE EXPRESSION; GENE REPRESSION; GENOME; HAIR; HAIR FOLLICLE; HAIR GROWTH; HIRSUTISM; HUMAN; LETTER; MALE TYPE ALOPECIA; MOLECULAR GENETICS; PRIORITY JOURNAL; SEBORRHEA; SKILL; SKIN; SKIN CELL;

ALOPECIA; CELLS, CULTURED; DOWN-REGULATION; GENE SILENCING; HAIR FOLLICLE; HUMANS; LIPOSOMES; OLIGONUCLEOTIDES, ANTISENSE; RECEPTORS, ANDROGEN; RNA, SMALL INTERFERING; SKIN; TRANSFECTION;

EID: 63149121107     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2008.12.008     Document Type: Letter

References (10)

1. Inui S., Fukuzato Y., Nakajima T., Yoshikawa K., and Itami S. Androgen inducible TGF-Beta 1 from balding dermal papilla cells inhibits epithelial cell growth: a clue to understand paradoxical effects of androgen on human hair. FASEB J 16 (2002) 1967-1969
2. Brodland D., and Muller S. Androgenetic alopecia (common baldness). Cutis 47 (1991) 173-176
3. Sinclair R. Male pattern androgenetic alopecia. BMJ 317 (1998) 865-869
4. Shaw J.C. Acne: effect of hormones on pathogenesis and management. Am J Clin Dermatol 20 (2002) 3001-3015
5. Sawaya M., and Shapiro J. Androgenetic alopecia, new approved and approved treatments. Dermatol Clin 18 (2000) 47-61
6. Balaña M.E., Alvarez Roger C., Dugour A.V., and Kerner N.A. Antiandrogen oligonucleotides: active principles in hair- and skin-derived culture cells. J Drugs Dermatol 3 (2004) 287-294
7. Maksymowych W.P., Blackburn Jr. W.D., Tami J.A., and Shanahan Jr. W.R. A randomized, placebo controlled trial of an antisense oligodeoxynucleotide to intercellular adhesion molecule-1 in the treatment of severe rheumatoid arthritis. J Rheumatol 29 (2002) 447-453
8. van Assche G., and Rutgeerts P. Antiadhesion molecule therapy in inflammatory bowel disease. Inflamm Bowel Dis 8 (2002) 291-300
9. Morris M.J., Tong W.P., Cordon-Cardo C., Drobnjak M., Kelly W.K., Slovin S.F., Terry K.L., et al. Phase I trial of BCL-2 antisense oligonucleotide (G3139) administered by continuous intravenous infusion in patients with advanced cancer. Clin Cancer Res 8 (2002) 679-683
10. Vitravene Study Group. A randomized controlled clinical trial of intravitreous fomivirsen for treatment of newly diagnosed peripheral cytomegalovirus retinitis in patients with AIDS. Am J Ophthalmol 133 (2002) 467-474